30% off. Use code at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

United States Biotechnology & Medical Research

Track

Revolution Medicines Inc (RVMD)

Track

Over the last 90 days, Revolution Medicines Inc. has seen significant insider selling activity, with a total sell value exceeding $79 million. Notably, Chief Operating Officer Margaret A. Horn has been involved in multiple planned and proposed sales totaling over $17 million. This activity coincides with a strong 90-day stock price increase of approximately 64.7%.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: RVMD Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Search

Download results Settings

Trades

Horn Margaret A

Chief Operating Officer

1 sale — total 100,000 USD

Planned sale 17 Jun 2026

Value US$2,488,461.44 | Price 102.35 | Shares 65,479

Cislini Jeff

General Counsel

1 sale — total 100,000 USD

Planned sale 16 Jun 2026

Value US$3,755,830.58 | Price 78.68 | Shares 15,595

Mancini Anthony

See Remarks

1 sale — total 100,000 USD

Planned sale 16 Jun 2026

Value US$100,000.00 | Price 156.12 | Shares 1,000

GOLDSMITH MARK A

See Remarks

1 sale — total 100,000 USD

Planned sale 16 Jun 2026

Value US$100,000.00 | Price 156.12 | Shares 1,000

Kelsey Stephen Michael

See Remarks

1 sale — total 100,000 USD

Planned sale 16 Jun 2026

Value US$100,000.00 | Price 156.12 | Shares 1,000

Anders Jack

Chief Financial Officer

1 sale — total 100,000 USD

Planned sale 16 Jun 2026

Value US$100,000.00 | Price 156.12 | Shares 1,000

Horn Margaret A

Chief Operating Officer

2 sales — total 200,000 USD

Planned sale 15 Jun 2026

Value US$100,000.00 | Price 160.17 | Shares 1,000

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

GOLDSMITH MARK A

Officer; Director

1 sale — total 100,000 USD

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

Cislini Jeff

Officer

1 sale — total 100,000 USD

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

Anders Jack

Officer

1 sale — total 100,000 USD

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

Mancini Anthony

Officer

1 sale — total 100,000 USD

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

Kelsey Stephen Michael

Officer

1 sale — total 100,000 USD

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

MARGARET A HORN

Officer

1 sale — total 100,000 USD

Proposed sale 15 Jun 2026

Value US$100,000.00 | Price 153.87 | Shares 1,000

Horn Margaret A

Chief Operating Officer

7 sales — total 700,000 USD

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 150.17 | Shares 1,000

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 149.64 | Shares 1,000

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 148.72 | Shares 1,000

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 147.27 | Shares 1,000

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 146.04 | Shares 1,000

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 145.15 | Shares 1,000

Planned sale 11 Jun 2026

Value US$100,000.00 | Price 144.28 | Shares 1,000

MARGARET A HORN

Officer

1 sale — total 100,000 USD

Proposed sale 11 Jun 2026

Value US$100,000.00 | Price 144.19 | Shares 1,000

Mancini Anthony

See Remarks

3 sales — total 480,611 USD

Planned sale 26 May 2026

Value US$65,177.41 | Price 154.82 | Shares 421

Planned sale 26 May 2026

Value US$308,121.80 | Price 154.06 | Shares 2,000

Planned sale 26 May 2026

Value US$107,311.61 | Price 153.30 | Shares 700

ANTHONY MANCINI

Officer

1 sale — total 473,019 USD

Proposed sale 26 May 2026

Value US$473,018.76 | Price 151.56 | Shares 3,121

Mancini Anthony

See Remarks

3 sales — total 413,129 USD

Planned sale 27 Apr 2026

Value US$53,734.00 | Price 134.34 | Shares 400

Planned sale 27 Apr 2026

Value US$139,387.76 | Price 132.88 | Shares 1,049

Planned sale 27 Apr 2026

Value US$220,007.03 | Price 131.66 | Shares 1,671

ANTHONY MANCINI

Officer

1 sale — total 422,136 USD

Proposed sale 27 Apr 2026

Value US$422,136.00 | Price 135.30 | Shares 3,120

GOLDSMITH MARK A

See Remarks

1 sale — total 18,010,488 USD

Planned sale 15 Apr 2026

Value US$18,010,488.00 | Price 150.09 | Shares 120,000

MARK A GOLDSMITH

Director; Officer

1 sale — total 17,641,200 USD

Proposed sale 15 Apr 2026

Value US$17,641,200.00 | Price 147.01 | Shares 120,000

Mancini Anthony

See Remarks

6 sales — total 7,157,644 USD

Planned sale 25 Mar 2026

Value US$38,882.84 | Price 97.21 | Shares 400

Planned sale 25 Mar 2026

Value US$1,064,200.38 | Price 96.43 | Shares 11,036

Planned sale 25 Mar 2026

Value US$2,013,415.69 | Price 95.49 | Shares 21,086

Planned sale 25 Mar 2026

Value US$294,520.28 | Price 94.16 | Shares 3,128

Planned sale 25 Mar 2026

Value US$167,801.40 | Price 93.22 | Shares 1,800

Proposed sale 25 Mar 2026

Value US$3,578,823.12 | Price 95.56 | Shares 37,450

Cislini Jeff

General Counsel

1 sale — total 113,323 USD

Planned sale 19 Mar 2026

Value US$113,322.72 | Price 97.44 | Shares 1,163

JEFFREY TODD CISLINI

Officer

1 sale — total 114,102 USD

Proposed sale 19 Mar 2026

Value US$114,101.93 | Price 98.11 | Shares 1,163

Wei Lin

Chief Medical Officer

1 sale — total 206,223 USD

Planned sale 17 Mar 2026

Value US$206,222.87 | Price 99.48 | Shares 2,073

Kelsey Stephen Michael

See Remarks

1 sale — total 427,965 USD

Planned sale 17 Mar 2026

Value US$427,964.68 | Price 99.48 | Shares 4,302

GOLDSMITH MARK A

See Remarks

1 sale — total 1,280,412 USD

Planned sale 17 Mar 2026

Value US$1,280,412.23 | Price 99.48 | Shares 12,871

Horn Margaret A

Chief Operating Officer

1 sale — total 455,919 USD

Planned sale 17 Mar 2026

Value US$455,918.67 | Price 99.48 | Shares 4,583

Anders Jack

Chief Financial Officer

1 sale — total 273,870 USD

Planned sale 17 Mar 2026

Value US$273,869.54 | Price 99.48 | Shares 2,753

Cislini Jeff

General Counsel

1 sale — total 178,567 USD

Planned sale 17 Mar 2026

Value US$178,567.32 | Price 99.48 | Shares 1,795

Wang Xiaolin

See Remarks

1 sale — total 199,956 USD

Planned sale 17 Mar 2026

Value US$199,955.60 | Price 99.48 | Shares 2,010

Wang Xiaolin

Officer

1 sale — total 227,264 USD

Proposed sale 16 Mar 2026

Value US$227,264.38 | Price 99.59 | Shares 2,282

Wei Lin

Officer

1 sale — total 227,862 USD

Proposed sale 16 Mar 2026

Value US$227,861.92 | Price 99.59 | Shares 2,288

Kelsey Stephen Michael

Officer

1 sale — total 388,501 USD

Proposed sale 16 Mar 2026

Value US$388,500.59 | Price 99.59 | Shares 3,901

Horn Margaret A

Officer

1 sale — total 470,264 USD

Proposed sale 16 Mar 2026

Value US$470,263.98 | Price 99.59 | Shares 4,722

GOLDSMITH MARK A

Officer; Director

1 sale — total 1,320,663 USD

Proposed sale 16 Mar 2026

Value US$1,320,662.99 | Price 99.59 | Shares 13,261

Cislini Jeff

Officer

1 sale — total 204,458 USD

Proposed sale 16 Mar 2026

Value US$204,458.27 | Price 99.59 | Shares 2,053

Anders Jack

Officer

1 sale — total 212,525 USD

Proposed sale 16 Mar 2026

Value US$212,525.06 | Price 99.59 | Shares 2,134

GOLDSMITH MARK A

See Remarks

13 sales — total 3,644,354 USD

Sale 2 Mar 2026

Value US$20,416.00 | Price 102.08 | Shares 200

Sale 2 Mar 2026

Value US$213,431.61 | Price 101.63 | Shares 2,100

Sale 2 Mar 2026

Value US$60,115.98 | Price 100.19 | Shares 600

Sale 2 Mar 2026

Value US$9,829.00 | Price 98.29 | Shares 100

Sale 2 Mar 2026

Value US$81,598.64 | Price 102.00 | Shares 800

Sale 2 Mar 2026

Value US$172,506.31 | Price 101.47 | Shares 1,700

Sale 2 Mar 2026

Value US$40,049.00 | Price 100.12 | Shares 400

Sale 2 Mar 2026

Value US$9,831.00 | Price 98.31 | Shares 100

Planned sale 2 Mar 2026

Value US$86,971.69 | Price 102.20 | Shares 851

Planned sale 2 Mar 2026

Value US$2,167,075.46 | Price 101.60 | Shares 21,329

Planned sale 2 Mar 2026

Value US$364,659.25 | Price 100.73 | Shares 3,620

Planned sale 2 Mar 2026

Value US$349,150.20 | Price 99.76 | Shares 3,500

Planned sale 2 Mar 2026

Value US$68,719.56 | Price 98.17 | Shares 700

JONATHAN GOLDSMITH REVOCABLE TRUST

Director; Officer

1 sale — total 306,060 USD

Proposed sale 2 Mar 2026

Value US$306,060.00 | Price 102.02 | Shares 3,000

THE REBECCA GOLDSMITH REVOCABLE TRUST

Director; Officer

1 sale — total 306,060 USD

Proposed sale 2 Mar 2026

Value US$306,060.00 | Price 102.02 | Shares 3,000

MARK A GOLDSMITH

Director; Officer

1 sale — total 3,060,600 USD

Proposed sale 2 Mar 2026

Value US$3,060,600.00 | Price 102.02 | Shares 30,000

Cislini Jeff

General Counsel

1 sale — total 104,965 USD

Planned sale 21 Jan 2026

Value US$104,964.80 | Price 115.60 | Shares 908

JEFFREY TODD CISLINI

Officer

1 sale — total 105,528 USD

Proposed sale 21 Jan 2026

Value US$105,527.76 | Price 116.22 | Shares 908

Horn Margaret A

Chief Operating Officer

3 sales — total 7,542,023 USD

Planned sale 7 Jan 2026

Value US$174,930.00 | Price 102.90 | Shares 1,700

Planned sale 7 Jan 2026

Value US$2,056,621.73 | Price 101.79 | Shares 20,204

Planned sale 7 Jan 2026

Value US$5,310,470.77 | Price 100.02 | Shares 53,096

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-06-17	2026-06-17	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	65,479 -43.3% 102.35 US$2,488,461	65,479 -43.3%	102.35	US$2,488,461
2026-06-18	2026-06-16	PlS Planned sale	2.9 Cislini Jeff General Counsel Officer	15,595 -37.1% 78.68 US$3,755,831	15,595 -37.1%	78.68	US$3,755,831
2026-06-18	2026-06-16	PlS Planned sale	Mancini Anthony See Remarks Officer	60,591 +26.4% 321.19 US$3,521,482	60,591 +26.4%	321.19	US$3,521,482
2026-06-18	2026-06-16	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	1,000 -3.6% 156.12 US$100,000	1,000 -3.6%	156.12	US$100,000
2026-06-18	2026-06-16	PlS Planned sale	2.9 Kelsey Stephen Michael See Remarks Officer	1,000 -1.4% 156.12 US$100,000	1,000 -1.4%	156.12	US$100,000
2026-06-18	2026-06-16	PlS Planned sale	2.9 Anders Jack Chief Financial Officer Officer	1,000 -2.2% 156.12 US$100,000	1,000 -2.2%	156.12	US$100,000
2026-06-17	2026-06-15	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -27.6% 160.17 US$100,000	1,000 -27.6%	160.17	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	2.4 GOLDSMITH MARK A Officer; Director Executive Director	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	2.9 Cislini Jeff Officer Officer	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	2.9 Anders Jack Officer Officer	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	Mancini Anthony Officer Officer	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	2.9 Kelsey Stephen Michael Officer Officer	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	3.0 Horn Margaret A Officer Officer	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-15	PrS Proposed sale	3.0 MARGARET A HORN Officer Officer	1,000 153.87 US$100,000	1,000	153.87	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -0.1% 150.17 US$100,000	1,000 -0.1%	150.17	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -2.8% 149.64 US$100,000	1,000 -2.8%	149.64	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -1.1% 148.72 US$100,000	1,000 -1.1%	148.72	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -0.3% 147.27 US$100,000	1,000 -0.3%	147.27	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -0.4% 146.04 US$100,000	1,000 -0.4%	146.04	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -0.5% 145.15 US$100,000	1,000 -0.5%	145.15	US$100,000
2026-06-15	2026-06-11	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,000 -0.8% 144.28 US$100,000	1,000 -0.8%	144.28	US$100,000
2026-06-11	2026-06-11	PrS Proposed sale	3.0 MARGARET A HORN Officer Officer	1,000 144.19 US$100,000	1,000	144.19	US$100,000
2026-05-28	2026-05-26	PlS Planned sale	Mancini Anthony See Remarks Officer	421 -0.8% 154.82 US$65,177	421 -0.8%	154.82	US$65,177
2026-05-28	2026-05-26	PlS Planned sale	Mancini Anthony See Remarks Officer	2,000 -3.5% 154.06 US$308,122	2,000 -3.5%	154.06	US$308,122
2026-05-28	2026-05-26	PlS Planned sale	Mancini Anthony See Remarks Officer	700 -1.2% 153.30 US$107,312	700 -1.2%	153.30	US$107,312
2026-05-26	2026-05-26	PrS Proposed sale	ANTHONY MANCINI Officer Officer	3,121 151.56 US$473,019	3,121	151.56	US$473,019
2026-04-29	2026-04-27	PlS Planned sale	Mancini Anthony See Remarks Officer	400 -0.7% 134.34 US$53,734	400 -0.7%	134.34	US$53,734
2026-04-29	2026-04-27	PlS Planned sale	Mancini Anthony See Remarks Officer	1,049 -1.9% 132.88 US$139,388	1,049 -1.9%	132.88	US$139,388
2026-04-29	2026-04-27	PlS Planned sale	Mancini Anthony See Remarks Officer	1,671 -2.9% 131.66 US$220,007	1,671 -2.9%	131.66	US$220,007
2026-04-27	2026-04-27	PrS Proposed sale	ANTHONY MANCINI Officer Officer	3,120 135.30 US$422,136	3,120	135.30	US$422,136
2026-04-17	2026-04-15	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	120,000 -30.2% 150.09 US$18,010,488	120,000 -30.2%	150.09	US$18,010,488
2026-04-15	2026-04-15	PrS Proposed sale	2.4 MARK A GOLDSMITH Director; Officer Executive Director	120,000 147.01 US$17,641,200	120,000	147.01	US$17,641,200
2026-03-26	2026-03-25	PlS Planned sale	Mancini Anthony See Remarks Officer	400 -0.7% 97.21 US$38,883	400 -0.7%	97.21	US$38,883
2026-03-26	2026-03-25	PlS Planned sale	Mancini Anthony See Remarks Officer	11,036 -16.8% 96.43 US$1,064,200	11,036 -16.8%	96.43	US$1,064,200
2026-03-26	2026-03-25	PlS Planned sale	Mancini Anthony See Remarks Officer	21,086 -24.3% 95.49 US$2,013,416	21,086 -24.3%	95.49	US$2,013,416
2026-03-26	2026-03-25	PlS Planned sale	Mancini Anthony See Remarks Officer	3,128 -3.5% 94.16 US$294,520	3,128 -3.5%	94.16	US$294,520
2026-03-26	2026-03-25	PlS Planned sale	Mancini Anthony See Remarks Officer	1,800 -2.0% 93.22 US$167,801	1,800 -2.0%	93.22	US$167,801
2026-03-26	2026-03-25	PrS Proposed sale	Mancini Anthony Officer Officer	37,450 95.56 US$3,578,823	37,450	95.56	US$3,578,823
2026-03-19	2026-03-19	PlS Planned sale	2.9 Cislini Jeff General Counsel Officer	1,163 -1.9% 97.44 US$113,323	1,163 -1.9%	97.44	US$113,323
2026-03-19	2026-03-19	PrS Proposed sale	2.9 JEFFREY TODD CISLINI Officer Officer	1,163 98.11 US$114,102	1,163	98.11	US$114,102
2026-03-19	2026-03-17	PlS Planned sale	Wei Lin Chief Medical Officer Officer	2,073 -2.0% 99.48 US$206,223	2,073 -2.0%	99.48	US$206,223
2026-03-19	2026-03-17	PlS Planned sale	2.9 Kelsey Stephen Michael See Remarks Officer	4,302 -1.4% 99.48 US$427,965	4,302 -1.4%	99.48	US$427,965
2026-03-19	2026-03-17	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	12,871 -4.4% 99.48 US$1,280,412	12,871 -4.4%	99.48	US$1,280,412
2026-03-19	2026-03-17	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	4,583 -2.8% 99.48 US$455,919	4,583 -2.8%	99.48	US$455,919
2026-03-19	2026-03-17	PlS Planned sale	2.9 Anders Jack Chief Financial Officer Officer	2,753 -2.1% 99.48 US$273,870	2,753 -2.1%	99.48	US$273,870
2026-03-19	2026-03-17	PlS Planned sale	2.9 Cislini Jeff General Counsel Officer	1,795 -2.9% 99.48 US$178,567	1,795 -2.9%	99.48	US$178,567
2026-03-19	2026-03-17	PlS Planned sale	2.3 Wang Xiaolin See Remarks Officer	2,010 -1.7% 99.48 US$199,956	2,010 -1.7%	99.48	US$199,956
2026-03-13	2026-03-16	PrS Proposed sale	2.3 Wang Xiaolin Officer Officer	2,282 99.59 US$227,264	2,282	99.59	US$227,264
2026-03-13	2026-03-16	PrS Proposed sale	Wei Lin Officer Officer	2,288 99.59 US$227,862	2,288	99.59	US$227,862
2026-03-13	2026-03-16	PrS Proposed sale	2.9 Kelsey Stephen Michael Officer Officer	3,901 99.59 US$388,501	3,901	99.59	US$388,501
2026-03-13	2026-03-16	PrS Proposed sale	3.0 Horn Margaret A Officer Officer	4,722 99.59 US$470,264	4,722	99.59	US$470,264
2026-03-13	2026-03-16	PrS Proposed sale	2.4 GOLDSMITH MARK A Officer; Director Executive Director	13,261 99.59 US$1,320,663	13,261	99.59	US$1,320,663
2026-03-13	2026-03-16	PrS Proposed sale	2.9 Cislini Jeff Officer Officer	2,053 99.59 US$204,458	2,053	99.59	US$204,458
2026-03-13	2026-03-16	PrS Proposed sale	2.9 Anders Jack Officer Officer	2,134 99.59 US$212,525	2,134	99.59	US$212,525
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	200 -0.3% 102.08 US$20,416	200 -0.3%	102.08	US$20,416
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	2,100 -3.1% 101.63 US$213,432	2,100 -3.1%	101.63	US$213,432
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	600 -0.9% 100.19 US$60,116	600 -0.9%	100.19	US$60,116
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	100 -0.1% 98.29 US$9,829	100 -0.1%	98.29	US$9,829
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	800 -1.2% 102.00 US$81,599	800 -1.2%	102.00	US$81,599
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	1,700 -2.5% 101.47 US$172,506	1,700 -2.5%	101.47	US$172,506
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	400 -0.6% 100.12 US$40,049	400 -0.6%	100.12	US$40,049
2026-03-03	2026-03-02	S Sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	100 -0.1% 98.31 US$9,831	100 -0.1%	98.31	US$9,831
2026-03-03	2026-03-02	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	851 -0.3% 102.20 US$86,972	851 -0.3%	102.20	US$86,972
2026-03-03	2026-03-02	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	21,329 -6.8% 101.60 US$2,167,075	21,329 -6.8%	101.60	US$2,167,075
2026-03-03	2026-03-02	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	3,620 -1.1% 100.73 US$364,659	3,620 -1.1%	100.73	US$364,659
2026-03-03	2026-03-02	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	3,500 -1.1% 99.76 US$349,150	3,500 -1.1%	99.76	US$349,150
2026-03-03	2026-03-02	PlS Planned sale	2.4 GOLDSMITH MARK A See Remarks Executive Director	700 -0.2% 98.17 US$68,720	700 -0.2%	98.17	US$68,720
2026-03-02	2026-03-02	PrS Proposed sale	2.4 JONATHAN GOLDSMITH REVOCABLE TRUST Director; Officer Executive Director	3,000 102.02 US$306,060	3,000	102.02	US$306,060
2026-03-02	2026-03-02	PrS Proposed sale	2.4 THE REBECCA GOLDSMITH REVOCABLE TRUST Director; Officer Executive Director	3,000 102.02 US$306,060	3,000	102.02	US$306,060
2026-03-02	2026-03-02	PrS Proposed sale	2.4 MARK A GOLDSMITH Director; Officer Executive Director	30,000 102.02 US$3,060,600	30,000	102.02	US$3,060,600
2026-01-23	2026-01-21	PlS Planned sale	2.9 Cislini Jeff General Counsel Officer	908 -1.9% 115.60 US$104,965	908 -1.9%	115.60	US$104,965
2026-01-21	2026-01-21	PrS Proposed sale	2.9 JEFFREY TODD CISLINI Officer Officer	908 116.22 US$105,528	908	116.22	US$105,528
2026-01-09	2026-01-07	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	1,700 -1.2% 102.90 US$174,930	1,700 -1.2%	102.90	US$174,930
2026-01-09	2026-01-07	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	20,204 -12.4% 101.79 US$2,056,622	20,204 -12.4%	101.79	US$2,056,622
2026-01-09	2026-01-07	PlS Planned sale	3.0 Horn Margaret A Chief Operating Officer Officer	53,096 -24.6% 100.02 US$5,310,471	53,096 -24.6%	100.02	US$5,310,471

Explore more

More insider trading research around Revolution Medicines Inc

More insider trades in United States

Similar Healthcare companies with insider activity

More Pharmaceuticals & Medical Research companies with insider activity

More Biotechnology & Medical Research companies with insider activity

Insider trading in North America